Sawada Y, Hatori M, Yamamoto H, Nishio M, Miyaki T, Oki T
Bristol-Myers Research Institute, Ltd., Tokyo Research Center, Japan.
J Antibiot (Tokyo). 1990 Oct;43(10):1223-9. doi: 10.7164/antibiotics.43.1223.
Pradimicin FA-1 was produced via directed biosynthesis with substitution of D-serine for D-alanine in the 15-position of pradimicin A. This substitution was achieved by the addition of D-serine to the culture medium of Actinomadura hibisca P157-2. Likewise, pradimicin FA-2 was co-produced along with pradimicin FA-1 when the pradimicins A and C producing strain, A. hibisca A2493 was grown in D-serine-supplemented medium. The new pradimicin analogs share a common core structure of 5,6-dihydrobenzo[a]naphthacenequinone substituted by D-serine at C-15, but differ in the disaccharide moiety at C-5. Pradimicin FA-1 has an N-methylamino sugar and D-xylose. Pradimicin FA-2 is the des-N-methyl analog of pradimicin FA-1. The in vitro and in vivo antifungal activity of the analogs was comparable to that of pradimicin A.
普拉地霉素FA-1是通过定向生物合成产生的,在普拉地霉素A的15位用D-丝氨酸取代D-丙氨酸。这种取代是通过向 hibisca P157-2 马杜拉放线菌的培养基中添加D-丝氨酸来实现的。同样,当产生普拉地霉素A和C的菌株 hibisca A2493 在添加了D-丝氨酸的培养基中生长时,普拉地霉素FA-2与普拉地霉素FA-1一起共同产生。新的普拉地霉素类似物具有一个共同的核心结构,即5,6-二氢苯并[a]萘并蒽醌,在C-15位被D-丝氨酸取代,但在C-5位的二糖部分有所不同。普拉地霉素FA-1具有一个N-甲基氨基糖和D-木糖。普拉地霉素FA-2是普拉地霉素FA-1的去N-甲基类似物。这些类似物的体外和体内抗真菌活性与普拉地霉素A相当。